Allogene Therapeutics, Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allogene Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allogene Therapeutics, Inc. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2020 | ALLO | Allogene Therapeut ... | Belldegrun Arie | Option Exercise | A | 18.22 | 379,066 | 6,906,583 | 379,066 | ||
| Mar 20 2020 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Option Exercise | A | 18.22 | 568,600 | 10,359,892 | 568,600 | |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Option Exercise | A | 18.22 | 109,600 | 1,996,912 | 109,600 | |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Grant | A | 0.00 | 30,800 | 0 | 93,821 | 63 K to 93.8 K (+48.87 %) |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Option Exercise | A | 18.22 | 109,600 | 1,996,912 | 109,600 | |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Grant | A | 0.00 | 30,800 | 0 | 135,962 | 105.2 K to 136 K (+29.29 %) |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Option Exercise | A | 18.22 | 109,600 | 1,996,912 | 109,600 | |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Grant | A | 0.00 | 30,800 | 0 | 78,706 | 47.9 K to 78.7 K (+64.29 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Sell | S | 19.19 | 3,750 | 71,980 | 63,021 | 66.8 K to 63 K (-5.62 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 20.25 | 300 | 6,075 | 47,906 | 48.2 K to 47.9 K (-0.62 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 19.70 | 5,150 | 101,433 | 47,257 | 52.4 K to 47.3 K (-9.83 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Sell | S | 20.06 | 1,625 | 32,603 | 2,214,914 | 2.2 M to 2.2 M (-0.07 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Sell | S | 19.24 | 18,710 | 360,012 | 2,215,426 | 2.2 M to 2.2 M (-0.84 %) |
| Mar 11 2020 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,217 | 0 | 1,015,297 | 1 M to 1 M (+0.82 %) | |
| Mar 11 2020 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | J | 0.00 | 9,391 | 0 | 2,234,136 | 2.2 M to 2.2 M (+0.42 %) |
| Mar 11 2020 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | J | 0.00 | 9,402 | 0 | 1,191,910 | 1.2 M to 1.2 M (+0.80 %) |